Astria Therapeutics, Inc. (ATXS)
Total Valuation
ATXS has a market cap or net worth of $772.76 million. The enterprise value is $526.56 million.
Market Cap | 772.76M |
Enterprise Value | 526.56M |
Important Dates
The last earnings date was Monday, March 4, 2024, after market close.
Earnings Date | Mar 4, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ATXS has 54.90 million shares outstanding. The number of shares has increased by 106.03% in one year.
Shares Outstanding | 54.90M |
Shares Change (YoY) | +106.03% |
Shares Change (QoQ) | +7.43% |
Owned by Insiders (%) | 0.49% |
Owned by Institutions (%) | 87.86% |
Float | 36.14M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 3.18 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 21.73, with a Debt / Equity ratio of 0.00.
Current Ratio | 21.73 |
Quick Ratio | n/a |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -34.70% and return on invested capital (ROIC) is -34.11%.
Return on Equity (ROE) | -34.70% |
Return on Assets (ROA) | -33.40% |
Return on Capital (ROIC) | -34.11% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.24M |
Employee Count | 59 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.09% in the last 52 weeks. The beta is 0.72, so ATXS's price volatility has been lower than the market average.
Beta (1Y) | 0.72 |
52-Week Price Change | +15.09% |
50-Day Moving Average | 13.54 |
200-Day Moving Average | 8.86 |
Relative Strength Index (RSI) | 48.17 |
Average Volume (30 Days) | 1,001,024 |
Short Selling Information
The latest short interest is 2.01 million, so 3.67% of the outstanding shares have been sold short.
Short Interest | 2.01M |
Short Previous Month | 1.70M |
Short % of Shares Out | 3.67% |
Short % of Float | 5.57% |
Short Ratio (days to cover) | 2.09 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -83.03M |
Pretax Income | -72.89M |
Net Income | -72.89M |
EBITDA | -72.89M |
EBIT | -72.89M |
Earnings Per Share (EPS) | -$2.42 |
Balance Sheet
The company has $246.53 million in cash and $329,000 in debt, giving a net cash position of $246.20 million or $4.48 per share.
Cash & Cash Equivalents | 246.53M |
Total Debt | 329,000 |
Net Cash | 246.20M |
Net Cash Per Share | $4.48 |
Equity / Book Value | 243.12M |
Book Value Per Share | 4.43 |
Working Capital | 239.39M |
Cash Flow
In the last 12 months, operating cash flow was -$68.45 million and capital expenditures -$25,000, giving a free cash flow of -$68.47 million.
Operating Cash Flow | -68.45M |
Capital Expenditures | -25,000 |
Free Cash Flow | -68.47M |
FCF Per Share | -$2.27 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ATXS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -106.03% |
Shareholder Yield | -106.03% |
Earnings Yield | -9.43% |
FCF Yield | -8.86% |
Analyst Forecast
The average price target for ATXS is $21.00, which is 49.20% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $21.00 |
Price Target Difference | 49.20% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 20, 2021. It was a reverse split with a ratio of 1:6.
Last Split Date | Aug 20, 2021 |
Split Type | Reverse |
Split Ratio | 1:6 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |